Vivani Medical posts investor deck outlining NanoPortal ultra-long-acting GLP-1 implant strategy for obesity marketPUBT·Aug 17 at 03:18 PMVANI-0.70%
Vivani Medical posts slide presentation under Reg FD; Exhibit 99.1 attachedTradingView·Aug 17 at 07:03 AMVANI-0.70%
Vivani Medical completes dosing in SLIM-1 Phase 1 trial of NPM-139 semaglutide implant for weight managementPUBT·Aug 6 at 07:06 AMVANI-0.70%
ClearOne (CLRO) Stock Soars Over 98% After Hours: Here's What You Need To Knowbenzinga_article·Aug 5 at 10:28 PMCLRO-1.13%VANI-0.70%
ClearOne cancels warrants for 437,500 shares at $5 exercise pricePUBT·Aug 5 at 05:42 PMVANI-0.70%CLRO-1.13%
ClearOne files draft information statement for Cortigent merger share issuancePUBT·Jul 17 at 04:24 PMCLRO-1.13%CRGT
Vivani Medical director, 10% owner Gregg Williams reports purchase of USD 999,999 common sharesPUBT·Jul 16 at 08:00 AMVANI-0.70%
Vivani Medical says first SLIM-1 dosing expected in August 2026 after CEO presentationTradingView·Jul 16 at 07:33 AMVANI-0.70%
Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk DealMarket Beat·Jul 15 at 06:02 PMVANI-0.70%NVO-3.13%
